Literature DB >> 34001295

Psychological distress among people with probable COVID-19 infection: analysis of the UK Household Longitudinal Study.

Claire L Niedzwiedz1, Michaela Benzeval2, Kirsten Hainey3, Alastair H Leyland3, Srinivasa Vittal Katikireddi3.   

Abstract

Studies exploring the longer-term effects of experiencing coronavirus disease-2019 (COVID-19) on mental health are lacking. We explored the relationship between reporting probable COVID-19 symptoms in April 2020 and psychological distress (measured using the General Health Questionnaire) 1, 2, 3, 5 and 7 months later. Data were taken from the UK Household Longitudinal Study, a nationally representative household panel survey of UK adults. Elevated levels of psychological distress were found up to 7 months after probable COVID-19, compared with participants with no likely infection. Associations were stronger among younger age groups and men. Further research into the psychological sequalae of COVID-19 is urgently needed.

Entities:  

Keywords:  COVID-19; Epidemiology; depressive disorders; infectious disease; mental health

Year:  2021        PMID: 34001295      PMCID: PMC8134894          DOI: 10.1192/bjo.2021.63

Source DB:  PubMed          Journal:  BJPsych Open        ISSN: 2056-4724


Background

Considerable concerns exist about the longer-term effects of experiencing coronavirus disease-2019 (COVID-19).[1] However, population-based data remain rare, with the majority of COVID-19 research focused on severe adverse physical consequences of acute disease. There is growing evidence that a substantial number of people experience persisting symptoms such as fatigue and chest pain months after infection.[2] Although the mental health consequences of societal changes during the pandemic (including lockdown) have been extensively studied,[3,4] research on the impact of COVID-19 infection on mental health is limited. Research from previous coronavirus outbreaks demonstrates potential for psychiatric consequences of infection.[5] An initial study using administrative data from the USA demonstrated that COVID-19 infection was associated with an increased incidence of psychiatric diagnoses (particularly anxiety and insomnia) in the following 14–90 days.[6] Studies have also demonstrated that COVID-19 survivors who received emergency department evaluation in Milan had high levels of depression and anxiety 1 month following discharge[7] and COVID-19 patients in Chongqing, China had more symptoms of stress, anxiety and depression compared with healthy and psychiatric patient controls.[8] However, most existing studies have been limited by small, non-representative samples and those based on electronic health records may not capture individuals with more minor acute COVID-19 symptoms or those with less severe psychological problems that do not present to health services. Changes in healthcare-seeking and treatment may lead to substantial potential bias in the context of a pandemic, where disruptions to health systems have been widespread. Data from surveys may therefore be better placed to capture the impact on mental health and need for intervention.

Aims

To explore the relationship between COVID-19 infection and mental health in the UK context, we assessed associations between experiencing COVID-19 symptoms and changes in psychological distress in a representative longitudinal survey of adults.

Method

The UK Household Longitudinal Study (also referred to as Understanding Society) is a nationally representative longitudinal household panel survey, based on a clustered stratified probability sample of UK households, described in detail previously.[9] All adults (aged ≥16 years) in chosen households are invited to participate. Data collection for each wave usually takes place over 24 months, with participants re-interviewed every year by online, face-to-face or telephone survey. We used pre-pandemic data from wave 9 (2017–19), which achieved a household response rate of over 80%.[10] In response to the COVID-19 pandemic, additional waves of data were collected in 2020 via online survey during April (24 to 30 April), May (27 May to 2 June), June (25 June to 1 July), July (24 to 31 July), September (24 September to 1 October) and November (24 November to 1 December).[11] The response rate for the first COVID wave was 48.6% of those who took part at wave 9.[12] Psychological distress was measured at each wave (pre-pandemic in 2017–19 and during the pandemic at each wave as above) via the General Health Questionnaire 12-item instrument (GHQ-12).[13] GHQ-12 assesses psychological distress and respondents reporting a score of 4 or more are likely experiencing symptoms to a clinically significant level.[3] Self-reported symptoms of cough, fever and anosmia allowed identification of individuals with probable COVID-19 infection in April 2020 (see Supplementary Material available at https://doi.org/10.1192/bjo.2021.63). Of 42 people reporting hospital admission for COVID-19 in April 2020, 34 were classified as probable COVID-19 according to our definition. We assessed associations between probable COVID-19 infection and psychological distress at 1, 2, 3, 5 and 7 months later using logistic regression, with models adjusted to account for pre-pandemic psychological distress (GHQ score) and other covariates (gender, age, ethnicity and long-standing illness or disability). We also conducted subgroup analyses by age group (under 45, 45–64, ≥65 years) and gender (men, women) to investigate potential effect modification by demographic characteristics associated with COVID-19. Analyses used inverse probability weights to adjust for non-response and standard errors were adjusted for the complex survey design. Missing data were excluded from analyses, but if participants were missing pre-pandemic wave 9 data responses from wave 10 were used if available. Statistical analyses were performed in Stata/MP 15.1. The University of Essex Ethics Committee approved all data collection for the Understanding Society main survey and COVID waves, which were performed in accordance with the Declaration of Helsinki. All survey participants provided fully informed consent. No additional ethical approval was necessary for this secondary data analysis.

Results

In total, 8.9% (n = 1112) of 12 492 participants experienced probable COVID-19 symptoms in April 2020. Psychological distress was more prevalent in May (27.4%, 95% CI 25.9–28.9), reduced to 20.8% (95% CI 19.4–22.3) in July, before increasing again to 26.5% (95% CI 24.8–28.2) in November, corresponding with the UK winter lockdown. The characteristics of participants are described in Supplementary Table 1. In comparison with participants without probable COVID-19 infection, psychological distress was more common at 1 (odds ratio (OR) = 1.39, 95% CI: 1.10–1.76), 2 (OR = 1.38, 95% CI 1.05–1.81), 3 (OR = 1.31, 95% CI 0.99–1.72), 5 (OR = 1.42, 95% CI 1.05–1.92) and 7 (OR = 1.47, 95% CI 1.04–2.07) months after reporting COVID-19 symptoms in adjusted analyses (Table 1 and Supplementary Table 2–6).
Table 1

Associations between probable coronavirus disease-2019 (COVID-19) in April 2020 and psychological distress (General Health Questionnaire (GHQ-12) ‘case’) up to 7 months later stratified by age group and gender

1 month later (May 2020)2 months later (June 2020)3 months later (July 2020)5 months later (September 2020)7 months later (November 2020)
Overall
No likely infection (reference)11111
Probable infection,b OR (95% CI)1.39** (1.10–1.76)1.38* (1.05–1.81)1.31 (0.99–1.72)1.42* (1.05–1.92)1.47* (1.04–2.07)
n12 49211 94911 56311 00910 379
By gender
Men, OR (95% CI)1.52* (1.05–2.20)1.57* (1.04–2.37)1.43 (0.91–2.24)1.36 (0.88–2.12)1.77** (1.20–2.61)
n51384908475945564283
Women, OR (95% CI)1.30 (0.98–1.75)1.31 (0.94–1.81)1.25 (0.86–1.82)1.46 (0.98–2.19)1.30 (0.82–2.07)
n72796969673063796022
By age group
Under 45 years, OR (95% CI)1.51* (1.07–2.13)1.43 (0.91–2.26)1.20 (0.80–1.78)1.39 (0.89–2.18)1.74* (1.02–2.95)
n34263169299627352481
45–64 years, OR (95% CI)1.24 (0.81–1.90)1.39 (0.87–2.22)1.38 (0.85–2.25)1.53 (0.94–2.49)1.27 (0.67–2.38)
n52795045492447244485
≥65 years, OR (95% CI)1.16 (0.52–2.58)1.14 (0.63–2.04)1.33 (0.68–2.60)1.23 (0.52–2.92)1.14 (0.59–2.20)
n35473511343233293203

Results for each time point include people who participated in wave 9, April 2020 and the respective follow-up wave from May to November 2020.

Adjusted for age, gender, ethnicity, limiting long-standing illness, GHQ-12 at wave 9 (2017–19).

*P < 0.05, **P < 0.01, ***P < 0.001.

Associations between probable coronavirus disease-2019 (COVID-19) in April 2020 and psychological distress (General Health Questionnaire (GHQ-12) ‘case’) up to 7 months later stratified by age group and gender Results for each time point include people who participated in wave 9, April 2020 and the respective follow-up wave from May to November 2020. Adjusted for age, gender, ethnicity, limiting long-standing illness, GHQ-12 at wave 9 (2017–19). *P < 0.05, **P < 0.01, ***P < 0.001. Subgroup analyses demonstrated stronger associations in men (OR = 1.52 in May, 95% CI 1.05–2.20) and younger adults (OR = 1.51 in May, 95% CI 1.07–2.13), with some differences in the strength of associations at different time points.

Discussion

Main findings

Our study suggests that COVID-19 infection could lead to an increase in clinically significant psychological distress that persists months after infection and is additional to the mental health impact of societal changes during the pandemic. Younger people and men with probable COVID-19 infection were more likely to report clinical levels of psychological distress compared with older age groups and women. There were some differences in the strength of associations over time that require further investigation to understand whether factors, such as lockdown restrictions, modify the association between COVID-19 symptoms and mental health.

Strengths and limitations

Our findings add to the growing evidence that COVID-19 infection may have a direct impact on mental health[8,14] that persists months after initial symptoms.[6,7] Study strengths include the longitudinal data over multiple points of follow-up during the pandemic, the representative UK sample and accounting for pre-pandemic mental health to limit reverse causation. Important limitations include the ascertainment of COVID-19 infection, based on self-report only (not confirmed by a laboratory test) and the classification of probable COVID-19 infection at only one time point. However, misclassification may be more likely to result in underestimation of any underlying association. Further research based on confirmed infection is required, as is research that takes into account the fluctuating nature of symptoms (i.e. ‘long-COVID’) and research that compares the impact of COVID with that of other illnesses, such as pneumonia. The self-reported nature of the exposure and outcome measures also means we cannot rule out the possibility of reverse causation in which poor mental health influences the reporting of COVID-19 symptoms. Triangulation of survey and administrative data (such as primary care and psychotropic prescribing records) would be helpful to disentangle the discrepancy between likely clinical need and service use and help to overcome the limitations of self-reported data.

Implications

The potential adverse impact of COVID-19 infection on mental health reinforces the benefits of minimising COVID-19 infection among the general population, not only in those at greatest risk of mortality. When considered alongside the mental health impact generated by mitigation measures, there is potential for a high demand for mental health services resulting from the pandemic. Further research to examine the longer-term psychological sequelae of COVID-19 infection is urgently required.
  10 in total

1.  The validity of two versions of the GHQ in the WHO study of mental illness in general health care.

Authors:  D P Goldberg; R Gater; N Sartorius; T B Ustun; M Piccinelli; O Gureje; C Rutter
Journal:  Psychol Med       Date:  1997-01       Impact factor: 7.723

2.  Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic.

Authors:  Jonathan P Rogers; Edward Chesney; Dominic Oliver; Thomas A Pollak; Philip McGuire; Paolo Fusar-Poli; Michael S Zandi; Glyn Lewis; Anthony S David
Journal:  Lancet Psychiatry       Date:  2020-05-18       Impact factor: 27.083

3.  Long-term consequences of COVID-19: research needs.

Authors:  Dana Yelin; Eytan Wirtheim; Pauline Vetter; Andre C Kalil; Judith Bruchfeld; Michael Runold; Giovanni Guaraldi; Cristina Mussini; Carlota Gudiol; Miquel Pujol; Alessandra Bandera; Luigia Scudeller; Mical Paul; Laurent Kaiser; Leonard Leibovici
Journal:  Lancet Infect Dis       Date:  2020-09-01       Impact factor: 25.071

4.  A quantitative and qualitative study on the neuropsychiatric sequelae of acutely ill COVID-19 inpatients in isolation facilities.

Authors:  Fengyi Hao; Wilson Tam; Xiaoyu Hu; Wanqiu Tan; Li Jiang; Xiaojiang Jiang; Ling Zhang; Xinling Zhao; Yiran Zou; Yirong Hu; Xi Luo; Roger S McIntyre; Travis Quek; Bach Xuan Tran; Zhisong Zhang; Hai Quang Pham; Cyrus S H Ho; Roger C M Ho
Journal:  Transl Psychiatry       Date:  2020-10-19       Impact factor: 6.222

5.  Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA.

Authors:  Maxime Taquet; Sierra Luciano; John R Geddes; Paul J Harrison
Journal:  Lancet Psychiatry       Date:  2020-11-09       Impact factor: 27.083

6.  Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors.

Authors:  Mario Gennaro Mazza; Rebecca De Lorenzo; Caterina Conte; Sara Poletti; Benedetta Vai; Irene Bollettini; Elisa Maria Teresa Melloni; Roberto Furlan; Fabio Ciceri; Patrizia Rovere-Querini; Francesco Benedetti
Journal:  Brain Behav Immun       Date:  2020-07-30       Impact factor: 7.217

7.  A longitudinal study on the mental health of general population during the COVID-19 epidemic in China.

Authors:  Cuiyan Wang; Riyu Pan; Xiaoyang Wan; Yilin Tan; Linkang Xu; Roger S McIntyre; Faith N Choo; Bach Tran; Roger Ho; Vijay K Sharma; Cyrus Ho
Journal:  Brain Behav Immun       Date:  2020-04-13       Impact factor: 7.217

8.  Mental health and well-being during the COVID-19 pandemic: longitudinal analyses of adults in the UK COVID-19 Mental Health & Wellbeing study.

Authors:  Rory C O'Connor; Karen Wetherall; Seonaid Cleare; Heather McClelland; Ambrose J Melson; Claire L Niedzwiedz; Ronan E O'Carroll; Daryl B O'Connor; Steve Platt; Elizabeth Scowcroft; Billy Watson; Tiago Zortea; Eamonn Ferguson; Kathryn A Robb
Journal:  Br J Psychiatry       Date:  2021-06       Impact factor: 9.319

9.  Finding the 'right' GP: a qualitative study of the experiences of people with long-COVID.

Authors:  Tom Kingstone; Anna K Taylor; Catherine A O'Donnell; Helen Atherton; David N Blane; Carolyn A Chew-Graham
Journal:  BJGP Open       Date:  2020-12-15

10.  Mental health and health behaviours before and during the initial phase of the COVID-19 lockdown: longitudinal analyses of the UK Household Longitudinal Study.

Authors:  Claire L Niedzwiedz; Michael James Green; Michaela Benzeval; Desmond Campbell; Peter Craig; Evangelia Demou; Alastair Leyland; Anna Pearce; Rachel Thomson; Elise Whitley; Srinivasa Vittal Katikireddi
Journal:  J Epidemiol Community Health       Date:  2020-09-25       Impact factor: 6.286

  10 in total
  5 in total

1.  Mental health, financial, and social outcomes among older adults with probable COVID-19 infection: A longitudinal cohort study.

Authors:  Eleonora Iob; Andrew Steptoe; Paola Zaninotto
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-28       Impact factor: 12.779

Review 2.  The global evolution of mental health problems during the COVID-19 pandemic: A systematic review and meta-analysis of longitudinal studies.

Authors:  Jude Mary Cénat; Seyed Mohammad Mahdi Moshirian Farahi; Rose Darly Dalexis; Wina Paul Darius; Farid Mansoub Bekarkhanechi; Hannah Poisson; Cathy Broussard; Gloria Ukwu; Emmanuelle Auguste; Duy Dat Nguyen; Ghizlène Sehabi; Sarah Elizabeth Furyk; Andi Phaelle Gedeon; Olivia Onesi; Aya Mesbahi El Aouame; Samiyah Noor Khodabocus; Muhammad S Shah; Patrick R Labelle
Journal:  J Affect Disord       Date:  2022-07-14       Impact factor: 6.533

3.  Life orientation and psychological distress in COVID recovered patients-the role of coping as a mediator.

Authors:  Faiqa Yaseen; Marva Sohail
Journal:  Front Psychol       Date:  2022-09-06

4.  Psychological distress, depression, anxiety, and life satisfaction following COVID-19 infection: evidence from 11 UK longitudinal population studies.

Authors:  Ellen J Thompson; Jean Stafford; Bettina Moltrecht; Charlotte F Huggins; Alex S F Kwong; Richard J Shaw; Paola Zaninotto; Kishan Patel; Richard J Silverwood; Eoin McElroy; Matthias Pierce; Michael J Green; Ruth C E Bowyer; Jane Maddock; Kate Tilling; S Vittal Katikireddi; George B Ploubidis; David J Porteous; Nic Timpson; Nish Chaturvedi; Claire J Steves; Praveetha Patalay
Journal:  Lancet Psychiatry       Date:  2022-11       Impact factor: 77.056

5.  Anxiety and depression symptoms after COVID-19 infection: results from the COVID Symptom Study app.

Authors:  Kerstin Klaser; Ellen J Thompson; Long H Nguyen; Carole H Sudre; Michela Antonelli; Benjamin Murray; Liane S Canas; Erika Molteni; Mark S Graham; Eric Kerfoot; Liyuan Chen; Jie Deng; Anna May; Christina Hu; Andy Guest; Somesh Selvachandran; David A Drew; Marc Modat; Andrew T Chan; Jonathan Wolf; Tim D Spector; Alexander Hammers; Emma L Duncan; Sebastien Ourselin; Claire J Steves
Journal:  medRxiv       Date:  2021-07-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.